Physician profile
David A Hester
NPI 1780656462
$4,225.46
in general payments reported to CMS, 2019-2025
15 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,384 · 2020: $873 · 2021: $233 · 2022: $395 · 2023: $371 · 2024: $259 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,992.90 | 2020-2025 | Mako, Pangea, Alphavent |
| Exactech, INC. | $1,369.19 | 2019 | |
| Bioventus LLC | $272.02 | 2019-2025 | Xcell, Exogen Ultrasound Bone Healing System, Durolane |
| Vertex Pharmaceuticals Incorporated | $161.09 | 2024-2025 | |
| Innovation Technologies INC | $85.80 | 2022-2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $81.92 | 2021-2023 | Exparel, Iovera, Zilretta |
| Depuy Synthes Sales INC. | $57.50 | 2020-2025 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $47.23 | 2020-2021 | |
| Amgen INC. | $41.80 | 2024 | Prolia, Evenity |
| Treace Medical Concepts, INC. | $28.16 | 2024 | |
| Medtronic, INC. | $24.65 | 2025 | Aquamantys(Tm) |
| Vericel Corporation | $23.48 | 2024 | Maci |
| Pylant Medical | $14.97 | 2022 | |
| Davol INC. | $13.47 | 2025 | Arista |
| Smith+Nephew, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.